These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 20471863)
1. Rationale for the judicious use of placebos in PAH trials. White RJ; Hiremath J J Heart Lung Transplant; 2010 Jul; 29(7):826-7. PubMed ID: 20471863 [No Abstract] [Full Text] [Related]
3. Editor's response to "ethical issues associated with globalization of placebo-controlled trials in pulmonary arterial hypertension". Park MH; Rubin LJ J Heart Lung Transplant; 2010 Jul; 29(7):827-8. PubMed ID: 20417131 [No Abstract] [Full Text] [Related]
4. Treprostinil (Remodulin) for pulmonary arterial hypertension. Med Lett Drugs Ther; 2002 Sep; 44(1139):80-2. PubMed ID: 12237619 [No Abstract] [Full Text] [Related]
5. Module four: standards of care and clinical trials. Selgelid MJ Dev World Bioeth; 2005 Mar; 5(1):55-72. PubMed ID: 15748178 [TBL] [Abstract][Full Text] [Related]
6. "Geographical morality" revisited: international relations, international law, and the controversy over placebo controlled HIV clinical trials in developing countries. Fidler DP Harvard Int Law J; 2001; 42(2):299-354. PubMed ID: 15295848 [No Abstract] [Full Text] [Related]
7. New and future therapies in pulmonary arterial hypertension. Bull TM Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320 [TBL] [Abstract][Full Text] [Related]
8. Treatments for pulmonary arterial hypertension. Liu C; Liu K; Ji Z; Liu G Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344 [TBL] [Abstract][Full Text] [Related]
9. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Tenser RB; Polman CH Neurology; 2009 Mar; 72(13):1191-2; author reply 1192. PubMed ID: 19332703 [No Abstract] [Full Text] [Related]
10. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension]. Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007 [TBL] [Abstract][Full Text] [Related]
11. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension. Sahni J Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470 [No Abstract] [Full Text] [Related]
12. Prostacyclin therapy for pulmonary arterial hypertension: new directions. Gomberg-Maitland M; Preston IR Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316 [TBL] [Abstract][Full Text] [Related]
13. Viagra eases symptoms of pulmonary arterial hypertension in children. Senior K Drug Discov Today; 2005 Oct; 10(20):1337. PubMed ID: 16253866 [No Abstract] [Full Text] [Related]
14. Do we need controlled clinical trials in pulmonary arterial hypertension? Galiè N Eur Respir J; 2001 Jan; 17(1):1-3. PubMed ID: 11307737 [No Abstract] [Full Text] [Related]
15. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Tonelli AR; Alnuaimat H; Mubarak K Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088 [TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546 [TBL] [Abstract][Full Text] [Related]
17. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults. Buckley MS; Feldman JP Pharmacotherapy; 2010 Jul; 30(7):728-40. PubMed ID: 20575636 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis]. Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963 [TBL] [Abstract][Full Text] [Related]